玩弄秘书的奶又大又软,99香蕉国产精品偷在线观看,日本japanese熟睡人妻,99香蕉国产精品偷在线观看

咨詢熱線

15000266580

當(dāng)前位置:首頁  >  技術(shù)文章  >  日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

更新時間:2013-07-26      點擊次數(shù):3200

   日本研究人員獲得批準(zhǔn),可以開展利用干細(xì)胞療法治療老年性黃斑變性(age-related macular degeneration,AMD),一種引起老年人視力下降的主要疾病。日本的研究人員誘導(dǎo)AMD患者身上取下的皮膚細(xì)胞使其處于一種類似于干細(xì)胞的狀態(tài)后再將其轉(zhuǎn)至患者,以達(dá)到治療效果。

干細(xì)胞具有廣泛的性,具有廣泛的醫(yī)療前景。去年,Kyoto University的Shinya Yamanaka即憑借干細(xì)胞領(lǐng)域的研究獲得諾貝爾獎。

詳細(xì)英文報道:

Japanese researchers have won permission to embark on a pioneering clinical study of a stem cell therapy for age-related macular degeneration, a major cause of vision loss in aging patients. The planned trial is being hailed as the first human test of a stem cell therapy made from patients' own cells.

Japan provides an appropriate proving ground for induced pluripotent stem (iPS) cell therapies. Last year professor Shinya Yamanaka of Kyoto University won a piece of a Nobel Prize for his work on converting adult cells into stem cells. The stem cells have broad potential in medicine because they can evolve into a variety to cell types with the potential to repair diseased or damaged organs, and they skirt the political quagmire of harvesting stem cells from human embryos.

As AFP reported, researchers in the Japanese study plan to take skin cells from AMD patients, coax the cells into a stem-like state, and then reintroduce them to the patients. The study calls for testing the therapeutic approach in 6 patients, with the trial set to begin next year in Kobe. Applications to conduct the trial came from the Riken Center for Developmental Biology and the Institute of Biomedical Research and Innovation.

Stem cells offer a whole new way to treat vision problems. Today, AMD patients take injected therapies such as Eylea and Lucentis to combat the disease by inhibiting VEGF to stymie the formation of leaky blood vessels, which lead to deterioration of the eye tissue that is key to central vision.

However, with pioneering clinical trials comes great risk. As professor Chris Mason of University College London noted to the BBC, researchers lack evidence on the safety of iPS cells in humans. The hope is that using patients' own cells to generate the therapies could reduce the risk of their bodies rejecting the stem cells.

 

聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2025 上海復(fù)祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
技術(shù)支持:化工儀器網(wǎng)    管理登陸
中文在线А天堂中文在线新版| 久久不射| 久久久久人妻精品一区三寸蜜桃| 最美情侣韩国片免费观看| 成人妇女免费播放久久久| 亚洲熟妇色XXXXX欧美老妇Y| 色婷婷av一区二区三区| 亚洲精品久久激情国产片| 男女吃奶做爰猛烈紧视频| 日日噜噜噜噜夜夜爽亚洲精品| 夜夜爽一区二区三区精品| 人妻体内射精一区二区三区| 国产精品又黄又爽又色无遮挡| 亚洲AV无码精品色午夜APP| 猫咪AV成人永久网站在线观看| 日韩欧美在线综合网| 非缘勿扰电视剧全集36免费观看| 丰满白嫩人妻中出无码| 日韩精品无码一区二区中文字幕| 色老太BBWBBWBBW高潮| 国内永久免费CRM系统Z在线| 复读生与应届生高考录取有区别吗 | 一性一交一伦一片A片庆| 野外玩弄大乳孕妇| 高中女学生破苞视频免费| 12—13女人做A片| 亚洲国产精品久久人人爱| 精品国产AⅤ无码一区二区| 色窝窝无码一区二区三区成人网站 | 我和小娻孑在卧室做了| 色综合色狠狠天天综合色| 精品欧洲AV无码一区二区| 国产SM主人调教女M视频| 久久国产一区二区三区| 欧美性生交18XXXXX无码| 东北女人变态另类XXXX| 偷看各类WC女厕嘘嘘近距离| 国产精品久久久久久久久久妞妞| 国产精品成人一区二区三区无码| 99国产揄拍国产精品人妻| 人妻少妇精品中文字幕AV蜜桃|